HeartBeam Joins European EXIT-CVD Consortium to Study At-Home ECG Monitoring

• HeartBeam joined the European EXIT-CVD research consortium, led by University Medical Center Groningen and Royal Philips.
• It will lead HEART-CHECK, evaluating at-home ECG monitoring for early detection and triage of cardiac events in high-risk patients discharged following ACS.
• Its contribution will be in-kind, including devices and clinical expertise.
• The EUR 27.6 million project is co-funded by the EU Innovative Health Initiative and industry partners, encompassing 22 studies involving over 14,000 patients.
• The system is FDA-cleared only for arrhythmia assessment; heart attack assessment remains investigational, and HEART-CHECK use will be investigational without CE marking.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartbeam Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261015343006) on October 15, 2026, and is solely responsible for the information contained therein.